MTM(SH:688029) Xin Lang Cai Jing·2025-12-30 05:28Group 1 - The core point of the news is that Nanwei Medical has experienced a decline in stock price, dropping 1% to 81.83 yuan per share, with a total market value of 15.372 billion yuan and a cumulative drop of 1.89% over three consecutive days [1] - Nanwei Medical, established on May 10, 2000, and listed on July 22, 2019, specializes in the research, manufacturing, and sales of minimally invasive medical devices [1] - The revenue composition of Nanwei Medical includes 77.80% from endoscopic consumables, 13.17% from other categories, 7.28% from tumor intervention, 1.00% from visualization, and 0.74% from other supplementary sources [1] Group 2 - Jin Xin Fund has a significant holding in Nanwei Medical through its Jin Xin Quality Growth Mixed A Fund (018204), which held 2.89% of its net asset value in 2,300 shares, ranking it as the tenth largest holding [2] - The Jin Xin Quality Growth Mixed A Fund has experienced a year-to-date return of 53.63% and a one-year return of 49.89%, with a total fund size of 7.1923 million [2] - The fund manager, Huang Biao, has been in position for 4 years and 222 days, with the best fund return during his tenure being 121.14% [3]